Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
9.70
+0.80 (9.06%)
At close: Nov 4, 2026, 4:00 PM EST
9.57
-0.13 (-1.29%)
After-hours: Nov 4, 2026, 6:02 PM EST
Teladoc Health Revenue
Teladoc Health had revenue of $605.10M in the quarter ending September 30, 2026, a decrease of -3.41%. This brings the company's total for the last twelve months to $2.47B, down -2.38% year-over-year. In the year 2025, Teladoc Health had annual revenue of $2.53B, down -1.54%. That makes Teladoc Health the 4,344th largest company in the world by revenue and 1,175th in the United States.
Revenue (ttm)
$2.47B
Revenue Growth
-2.38%
P/S Ratio
0.72
Revenue / Employee
$440,740
Employees
5,600
Market Cap
1.77B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Teladoc Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.53B | -39.60M | -1.54% |
| Dec 31, 2024 | 2.57B | -32.84M | -1.26% |
| Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
| Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
| Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
| Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
| Dec 31, 2019 | 553.31M | 135.40M | 32.40% |
| Dec 31, 2018 | 417.91M | 184.63M | 79.14% |
| Dec 31, 2017 | 233.28M | 110.12M | 89.42% |
| Dec 31, 2016 | 123.16M | 45.77M | 59.15% |
| Dec 31, 2015 | 77.38M | 33.86M | 77.78% |
| Dec 31, 2014 | 43.53M | 23.62M | 118.67% |
| Dec 31, 2013 | 19.91M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Privia Health Group | 2.36B |
| Omnicell | 1.24B |
| GoodRx Holdings | 785.23M |
| Phreesia | 507.79M |
| Certara | 421.75M |
| HealthStream | 321.12M |
| Omada Health | 309.76M |
| Schrödinger | 259.04M |
TDOC News
- 12 hours ago - Teladoc price target raised to $9 from $7 at Barclays - TheFly
- 1 day ago - Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewsWire
- 2 days ago - Teladoc downgraded to Sell from Hold at Argus - TheFly
- 2 days ago - Teladoc price target raised to $10 from $7 at Oppenheimer - TheFly
- 2 days ago - Teladoc price target raised to $9 from $6.50 at UBS - TheFly
- 5 days ago - Teladoc price target raised to $10 from $8 at JPMorgan - TheFly
- 6 days ago - Teladoc price target raised to $6.50 from $5.50 at Stifel - TheFly
- 7 days ago - Teladoc Health Earnings Call Transcript: Q3 2026 - Transcripts